Targeted triple therapy tested for Tough-to-Treat colon cancer
NCT ID NCT06356597
Summary
This study is testing whether a combination of three drugs can help control advanced colorectal cancer in patients who have already tried other treatments. The treatment is specifically for people whose cancer has a certain type and who also have high levels of a specific gut bacteria. Researchers will measure if the treatment slows cancer growth and how long patients live.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai First People's Hospital
Shanghai, China
-
Shanghai Ninth People's Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.